{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T17:24:41Z","timestamp":1770225881961,"version":"3.49.0"},"reference-count":39,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,1,15]]},"DOI":"10.2169\/internalmedicine.5441-20","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T22:17:30Z","timestamp":1610662650000},"page":"209-216","source":"Crossref","is-referenced-by-count":13,"title":["The Clinical Features of Patients with Sarcoidosis and Malignant Diseases in Japan"],"prefix":"10.2169","volume":"60","author":[{"given":"Tsutomu","family":"Tamada","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Nara","sequence":"additional","affiliation":[{"name":"National Hospital Organization Akita National Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Gamo","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemi","family":"Aritake","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Gerontological and Home Healthcare Nursing, Course of Nursing, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itsuro","family":"Kazama","sequence":"additional","affiliation":[{"name":"Miyagi University, School of Nursing, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Ichinose","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisatoshi","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J. Sarcoidosis. Lancet 383: 1155-1167, 2014.","DOI":"10.1016\/S0140-6736(13)60680-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Chen ES, Moller DR. Etiologies of sarcoidosis. Clin Rev Allergy Immunol 49: 6-18, 2015.","DOI":"10.1007\/s12016-015-8481-z"},{"key":"3","unstructured":"3. Gupta D, Agarwal R, Aggarwal AN, Jindal SK. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J 30: 508-516, 2007."},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Ishige I, Usui Y, Takemura T, Eishi Y. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 354: 120-123, 1999.","DOI":"10.1016\/S0140-6736(98)12310-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Prezant DJ, Dhala A, Goldstein A, et al. The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest 116: 1183-1193, 1999.","DOI":"10.1378\/chest.116.5.1183"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hena KM, Yip J, Jaber N, et al. Clinical course of sarcoidosis in World Trade Center-exposed firefighters. Chest 153: 114-123, 2018.","DOI":"10.1016\/j.chest.2017.10.014"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. McDonough C, Gray GC. Risk factors for sarcoidosis hospitalization among U.S. Navy and Marine Corps personnel, 1981 to 1995. Mil Med 165: 630-632, 2000.","DOI":"10.1093\/milmed\/165.8.630"},{"key":"8","unstructured":"8. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170: 1324-1330, 2004."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Cohen PR, Kurzrock R. Sarcoidosis and malignancy. Clin Dermatol 25: 326-333, 2007.","DOI":"10.1016\/j.clindermatol.2007.03.010"},{"key":"10","unstructured":"10. Bonifazi M, Bravi F, Gasparini S, et al. Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies. Chest 147: 778-791, 2015."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Brincker H, Wilbek E. The incidence of malignant tumours in patients with respiratory sarcoidosis. Br J Cancer 29: 247-251, 1974.","DOI":"10.1038\/bjc.1974.64"},{"key":"12","unstructured":"12. S\u00f8gaard KK, Svaerke C, Thomsen RW, Norgaard M. Sarcoidosis and subsequent cancer risk: a Danish nationwide cohort study. Eur Respir J 45: 269-272, 2015."},{"key":"13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000455877","volume":"93","author":"N Arish","year":"2017","unstructured":"13. Arish N, Kuint R, Sapir E, et al. Characteristics of sarcoidosis in patients with previous malignancy: causality or coincidence? Respiration 93: 247-252, 2017.","journal-title":"Respiration","ISSN":"https:\/\/id.crossref.org\/issn\/0025-7931","issn-type":"print"},{"key":"14","unstructured":"14. Paparel P, Devonec M, Perrin P, et al. Association between sarcoidosis and testicular carcinoma: a diagnostic pitfall. Sarcoidosis Vasc Diffuse Lung Dis 24: 95-101, 2007."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Suen JS, Forse MS, Hyland RH, Chan CK. The malignancy-sarcoidosis syndrome. Chest 98: 1300-1302, 1990.","DOI":"10.1378\/chest.98.5.1300"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Massaguer S, Sanchez M, Castel T. Mediastinal sarcoidosis induced by high-dose alpha-2-interferon therapy in a patient with malignant melanoma. Eur Radiol 14: 1716-1717, 2004.","DOI":"10.1007\/s00330-003-2207-y"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Murphy KP, Kennedy MP, Barry JE, O&apos;Regan KN, Power DG. New-onset mediastinal and central nervous system sarcoidosis in a patient with metastatic melanoma undergoing CTLA4 monoclonal antibody treatment. Oncol Res Treat 37: 351-353, 2014.","DOI":"10.1159\/000362614"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Blank N, Lorenz HM, Ho AD, Witzens-Harig M. Sarcoidosis and the occurrence of malignant diseases. Rheumatol Int 34: 1433-1439, 2014.","DOI":"10.1007\/s00296-014-2983-5"},{"key":"19","unstructured":"19. Ungprasert P, Crowson CS, Matteson EL. Risk of malignancy among patients with sarcoidosis: a population-based cohort study. Arthritis Care Res 69: 46-50, 2017."},{"key":"20","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/resp.12369","volume":"19","author":"P Ungprasert","year":"2014","unstructured":"20. Ungprasert P, Srivali N, Wijarnpreecha K, Thongprayoon C, Cheungpasitporn W, Knight EL. Is the incidence of malignancy increased in patients with sarcoidosis? a systematic review and meta-analysis. Respirology 19: 993-998, 2014.","journal-title":"Respirology","ISSN":"https:\/\/id.crossref.org\/issn\/1323-7799","issn-type":"print"},{"key":"21","unstructured":"21. Hunninghake GW, Costabel U, Ando M, et al. ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16: 149-173, 1999."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 26: 319-338, 2005.","DOI":"10.1183\/09031936.05.00034805"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 160: 1668-1672, 1999.","DOI":"10.1164\/ajrccm.160.5.9904045"},{"key":"24","unstructured":"24. Ji J, Shu X, Li X, Sundquist K, Sundquist J, Hemminki K. Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden. Ann Oncol 20: 1121-1126, 2009."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Morimoto T, Azuma A, Abe S, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J 31: 372-379, 2008.","DOI":"10.1183\/09031936.00075307"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hunt BM, Vallieres E, Buduhan G, Aye R, Louie B. Sarcoidosis as a benign cause of lymphadenopathy in cancer patients. Am J Surg 197: 629-632, 2009.","DOI":"10.1016\/j.amjsurg.2009.01.004"},{"key":"27","unstructured":"27. Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 45: 884-891, 2015."},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391: 1023-1075, 2018.","DOI":"10.1016\/S0140-6736(17)33326-3"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Eishi Y. Etiologic link between sarcoidosis and <i>Propionibacterium acnes<\/i>. Respir Investig 51: 56-68, 2013.","DOI":"10.1016\/j.resinv.2013.01.001"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ichiyasu H, Suga M, Iyonaga K, Ando M. Role of monocyte chemoattractant protein-1 in <i>Propionibacterium acnes<\/i>-induced pulmonary granulomatosis. Microsc Res Tech 53: 288-297, 2001.","DOI":"10.1002\/jemt.1095"},{"key":"31","unstructured":"31. Butt S, Alzebdeh R, Kable TD, Soubani AO. Non-caseating granulomas in patients after the diagnosis of cancer: clinical characteristics and outcome. Sarcoidosis Vasc Diffuse Lung Dis 28: 44-9, 2011."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Reich JM. Neoplasia in the etiology of sarcoidosis. Eur J Intern Med 17: 81-87, 2006.","DOI":"10.1016\/j.ejim.2005.09.023"},{"key":"33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000346244","volume":"226","author":"G Buss","year":"2013","unstructured":"33. Buss G, Cattin V, Spring P, Malinverni R, Gilliet M. Two cases of interferon-alpha-induced sarcoidosis Koebnerized along venous drainage lines: new pathogenic insights and review of the literature of interferon-induced sarcoidosis. Dermatology 226: 289-297, 2013.","journal-title":"Dermatology","ISSN":"https:\/\/id.crossref.org\/issn\/1018-8665","issn-type":"print"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Schweitzer MD, Salamo O, Holt G, Donna E, Mirsaeidi M. Sarcoidosis onset after breast cancer; a potential association. Eur J Intern Med 44: e11-e12, 2017.","DOI":"10.1016\/j.ejim.2017.08.006"},{"key":"35","unstructured":"35. Sorensen HT, Mellemkjaer L, Nielsen GL, Baron JA, Olsen JH, Karagas MR. Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study. J Natl Cancer Inst 96: 709-711, 2004."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Candido J, Hagemann T. Cancer-related inflammation. J Clin Immunol 33: S79-S84, 2013.","DOI":"10.1007\/s10875-012-9847-0"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Kunkel SL, Chensue SW, Strieter RM, Lynch JP, Remick DG. Cellular and molecular aspects of granulomatous inflammation. Am J Respir Cell Mol Biol 1: 439-447, 1989.","DOI":"10.1165\/ajrcmb\/1.6.439"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Fehrenbach H, Zissel G, Goldmann T, et al. Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis. Eur Respir J 21: 421-428, 2003.","DOI":"10.1183\/09031936.03.00083002"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 3: 276-285, 2003.","DOI":"10.1038\/nrc1046"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/2\/60_5441-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T03:46:36Z","timestamp":1610768796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/2\/60_5441-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5441-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]}}}